Development of Extensively Drug-resistant Tuberculosis during Multidrug-resistant Tuberculosis Treatment

201093 citationsJournal Articlegreen Open Access

Authors

Sonya Shin · Brigham and Women's Hospital

Salmaan Keshavjee · Brigham and Women's Hospital

Irina Gelmanova · Partners In Health

Sidney Atwood · Brigham and Women's Hospital

Molly F. Franke · Harvard University

Sergey P. Mishustin · Tomsk Cancer Research Institute

А. К. Стрелис

Abstract

Early and rapid diagnosis, timely initiation of appropriate therapy, and programmatic efforts to optimize treatment adherence during MDR-TB therapy are crucial to avoiding the generation of excess XDR-TB in MDR-TB treatment programs.

Topics & Keywords

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis Mycobacterium research and diagnosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Respiratory and Critical Care Medicine

Volume 182, Issue 3, pp. 426-432

DOI: 10.1164/rccm.200911-1768oc

Field-Weighted Citation Impact: 3.21